Kimberly Schultz is an accomplished inventor based in Mountain View, CA. She has made significant contributions to the field of medical technology, particularly in non-invasive monitoring techniques. Her innovative approach has the potential to enhance patient care and improve diagnostic accuracy.

Latest Patents

Kimberly Schultz holds a patent for a method titled "Method for non-invasive monitoring of fluorescent tracer agent with diffuse reflection corrections." This method involves monitoring a time-varying fluorescence signal emitted from a fluorescent agent within a medium that has time-varying optical properties. The process includes providing a measurement data set with multiple entries, which consist of measurements taken from a patient before and after the administration of the fluorescent agent. The measurements may include signals detected by both unfiltered and filtered light detectors during specific illumination conditions. The method also identifies a post-agent administration portion of the data set and transforms the fluorescence signals to represent the detected intensity emitted solely by the fluorescent agent.

Career Highlights

Kimberly works at Medibeacon Inc., where she continues to develop and refine her innovative techniques. Her work is pivotal in advancing non-invasive monitoring technologies, which can lead to better patient outcomes and more efficient healthcare practices.

Collaborations

Some of her notable coworkers include Jennifer Keating and Edward Gerald Solomon, who contribute to the collaborative environment at Medibeacon Inc. Their combined expertise fosters innovation and drives the development of cutting-edge medical technologies.

Conclusion

Kimberly Schultz's contributions to non-invasive monitoring represent a significant advancement in medical technology. Her innovative methods have the potential to transform patient monitoring and improve healthcare delivery.

Profile summary based on public USPTO records.